Review Article

Medicolegal Considerations with Intravenous Tissue Plasminogen Activator in Stroke: A Systematic Review

Table 2

Physician/facility involved.

Faculty/facility involvedCases ( , %)Verdict in favor of ( , %)

ED physician involved25, 62.5%Defendant: 21, 84%
Plaintiff: 4, 16%
Neurologist involved8, 20%Defendant: 6, 75%
Plaintiff: 2, 25%
Other (PCP, hospitalist, ICU, and neurosurgeon)7, 17.5%Defendant: 5, 71.4%
Plaintiff: 1, 14.3%
NA: 1, 14.3%
Multiple physicians involved11, 27.5%Defendant: 10, 90.9%
Plaintiff: 1, 9.1%
Only hospital involved12, 30%Defendant: 4, 33.3%
Plaintiff: 7, 58.3%
NA: 1, 8.3%
Hospital involved36, 90%Defendant: 22, 61.1%
Plaintiff: 13, 36.1%
NA: 1, 2.8%
Type of hospital involvedOf total 36,
Community hospital: 27, 75%
University Hospital: 9, 25%
Community hospital: defendant: 17, 62.9%
plaintiff: 10, 37.03%
University hospital: defendant: 5, 55.6%
plaintiff: 3, 33.3%
NA: 1, 11.1%
In hospital strokes5 of total 40, 12.5%Defendant: 2, 40%
Plaintiff: 2, 40%
NA: 1, 20%